CALLIE CLARK: Open Payments
NPI 1487114484 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,356 in 133 payments from 21 companies in 2025. Trend: 2023 $1,769 · 2024 $1,747 · 2025 $2,356
Food & beverage: $2,356
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $483 |
| Madrigal Pharmaceuticals | 12 | $249 |
| Ardelyx, Inc. | 12 | $229 |
| Janssen Biotech, Inc. | 16 | $200 |
| QOL Medical, LLC | 8 | $194 |
| GENZYME CORPORATION | 7 | $148 |
| Lilly USA, LLC | 6 | $112 |
| Phathom Pharmaceuticals, Inc. | 6 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Celltrion USA Inc. | 5 | $95 |
Products named: RINVOQ, REZDIFFRA, IBSRELA, TREMFYA, DUPIXENT, Sucraid, OMVOH, CREON.
Industry payments across AL — which companies pay providers there.
